Biotechnology News 1 January 2026

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

New York, Jan 5, 2026, 14:59 EST — Regular session Thermo Fisher Scientific Inc shares rose about 2.4% in afternoon trading on Monday after Evercore ISI raised its price target to $650 from $610 and kept an “outperform” rating, a

5 January 2026

Biotechnology·Earnings Reports·Financial News·Investing·Stock Market

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

New York, January 5, 2026, 14:30 (EST) — Regular session BridgeBio Pharma shares slid 7.5% to $72.34 in afternoon trading on Monday after opening at $78.44 and touching $79.24 earlier in the session. The drop outpaced a roughly 2.2% decline

5 January 2026

Biotechnology·Healthcare Industry·Investment Analysis·Pharma News·Stock Market

Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings

NEW YORK, January 4, 2026, 19:53 ET — Market closed Thermo Fisher Scientific Inc shares closed Friday up about 2.3% at $592.51, beating the broader market’s modest advance in the first session of 2026. Reuters The move matters heading into

5 January 2026

Biotechnology·Earnings Reports·Financial News·Investment Strategies·Stock Market

Wave Life Sciences stock drops 6% as WVE traders size up next obesity data

NEW YORK, Jan 3, 2026, 20:55 ET — Market closed Wave Life Sciences Ltd (WVE) shares closed down 6.2% on Friday at $15.95, ending the first full U.S. trading session of 2026 with a sharp pullback. The slide matters because

4 January 2026

Biotechnology·Financial Analysis·Investment News·Stock Market

Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

NEW YORK, Jan 2, 2026, 14:37 ET — Regular session Shares of Spyre Therapeutics, Inc. slid about 7% on Friday, falling to $30.48 in afternoon trading after touching a session low of $30.11. The stock opened at $32.76 and was

2 January 2026

Biotechnology·Financial News·Healthcare·Investing·Stock Market

Nuvation Bio stock today: NUVB slides nearly 7% as early gains fade

NEW YORK, Jan 2, 2026, 2:49 PM ET — Regular session Shares of Nuvation Bio Inc fell about 6.8% to $8.35 in afternoon trading on Friday, after opening at $8.97 and swinging between $9.13 and $8.30. About 3.3 million shares

2 January 2026

Biotechnology·Investment News·Market Trends·Stock Market

Wave Life Sciences stock tumbles 8.5% in first 2026 session as traders refocus on next WVE-007 readout

NEW YORK, January 2, 2026, 14:13 ET — Regular session Wave Life Sciences Ltd shares slid on Friday, giving back part of last month’s obesity-driven run as the biotech sector wobbled in the first U.S. session of 2026. The stock

2 January 2026

Biotechnology·Company Earnings·Investment News·Pharma Industry·Stock Market

INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus

NEW YORK, Jan 2, 2026, 11:40 ET — Regular session Shares of Intelligent Bio Solutions Inc slid on Friday as investors digested the micro-cap medtech company’s $10 million private placement announced late Wednesday. The stock was down 12.1% at $8.38

2 January 2026

Biotechnology·Company Analysis·Financial News·Investing·Stock Market

Cytokinetics (CYTK) stock closes up 3.5% into year-end as Myqorzo launch nears, insider sale disclosed

NEW YORK, January 1, 2026, 21:17 ET — Market closed Cytokinetics, Incorporated shares ended Wednesday up 3.5% at $63.54, the final U.S. trading session of 2025, after markets closed Thursday for the New Year’s Day holiday. The stock has traded

2 January 2026

Biotechnology·Investments·Market News·Pharma Industry·Stocks

CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

NEW YORK, January 1, 2026, 18:59 ET — Market closed Shares of CRISPR Therapeutics AG ended the last trading session of 2025 down 1.4% at $52.44. U.S. stock markets were closed on Thursday for New Year’s Day, according to the

2 January 2026

Biotechnology·Financial News·Investing·Stock Market

Axsome Therapeutics (AXSM) stock jumps after FDA sets April 30 decision for Alzheimer’s agitation drug

NEW YORK, January 1, 2026, 16:58 ET — Market closed Axsome Therapeutics shares jumped about 23% in the most recent session on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental application for AXS-05 to

1 January 2026

Biotechnology·FDA News·Pharmaceutical Industry·Stock Market

Regencell Bioscience (RGC) stock slid 8% into the New Year’s Day market shutdown — what’s next

NEW YORK, January 1, 2026, 10:46 ET — Market closed. Regencell Bioscience Holdings’ shares last closed down 8.3% at $21 on Wednesday, just before U.S. markets shut for the New Year’s Day holiday. New York Stock Exchange The latest swing

1 January 2026

Biotechnology·Financial News·Investing·Market Analysis·Stock Market

Biotechnology News 1 January 2026 - 5 January 2026